Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure
Summary: in the present-day routine clinical practice, measurement of GFR in the absence of risk factors for the development of CKD is not common. However, recent research shows that evaluation of GFR in patients with NAFLD is imperative even in the absence of classical risk factors for CKD. Early d...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2015-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/347 |
id |
doaj-4787dbd0921e46b8909822487b8419aa |
---|---|
record_format |
Article |
spelling |
doaj-4787dbd0921e46b8909822487b8419aa2021-07-28T13:29:21ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902015-12-0101311812310.21518/2079-701X-2015-13-118-123347Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failureO. M. Drapkina0E. V. Zyatenkova1National Research Center for Preventive Medicine, MoscowFirst Moscow State Medical University named after I.M. SechenovSummary: in the present-day routine clinical practice, measurement of GFR in the absence of risk factors for the development of CKD is not common. However, recent research shows that evaluation of GFR in patients with NAFLD is imperative even in the absence of classical risk factors for CKD. Early detection of kidney damage in patients with CHF and NAFLD will enable to define the right dose of pharmacotherapy and avoid overdose.https://www.med-sovet.pro/jour/article/view/347хсннажбпфиброз печенистеатоз печени скфхроническая болезнь почекn-терминальный пропептид коллагена iii типаfatty liver indexnafld fibrosis score |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
O. M. Drapkina E. V. Zyatenkova |
spellingShingle |
O. M. Drapkina E. V. Zyatenkova Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure Медицинский совет хсн нажбп фиброз печени стеатоз печени скф хроническая болезнь почек n-терминальный пропептид коллагена iii типа fatty liver index nafld fibrosis score |
author_facet |
O. M. Drapkina E. V. Zyatenkova |
author_sort |
O. M. Drapkina |
title |
Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure |
title_short |
Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure |
title_full |
Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure |
title_fullStr |
Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure |
title_full_unstemmed |
Renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure |
title_sort |
renal disease in patients with nonalcoholic fatty liver disease and chronic heart failure |
publisher |
Remedium Group LLC |
series |
Медицинский совет |
issn |
2079-701X 2658-5790 |
publishDate |
2015-12-01 |
description |
Summary: in the present-day routine clinical practice, measurement of GFR in the absence of risk factors for the development of CKD is not common. However, recent research shows that evaluation of GFR in patients with NAFLD is imperative even in the absence of classical risk factors for CKD. Early detection of kidney damage in patients with CHF and NAFLD will enable to define the right dose of pharmacotherapy and avoid overdose. |
topic |
хсн нажбп фиброз печени стеатоз печени скф хроническая болезнь почек n-терминальный пропептид коллагена iii типа fatty liver index nafld fibrosis score |
url |
https://www.med-sovet.pro/jour/article/view/347 |
work_keys_str_mv |
AT omdrapkina renaldiseaseinpatientswithnonalcoholicfattyliverdiseaseandchronicheartfailure AT evzyatenkova renaldiseaseinpatientswithnonalcoholicfattyliverdiseaseandchronicheartfailure |
_version_ |
1721274466123644928 |